Usana Health Sciences Inc (USNA)
EBITDA Growth
-56.83%
TTM · Period ending:
USNA EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-56.83%period ending
Latest reported-56.83%period ending
USNA TTM EBITDA YoY % (156.14% → -56.83%)
Year-over-year change
High-resolution chart · PNG
USNA ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| -56.8296% | |
| -14.7209% | |
| -16.9834% | |
| -26.4095% | |
| -16.2941% | |
| -22.6906% | |
| -19.697% | |
| -4.6191% | |
| -5.6759% | |
| -2.7612% | |
| -5.4622% | |
| -14.2641% | |
| -21.7809% | |
| -31.2837% | |
| -32.4892% | |
| -34.9849% | |
| -28.7708% | |
| -11.3353% | |
| -3.7244% | |
| 11.1648% | |
| 20.2776% | |
| 17.6297% | |
| 17.5441% | |
| 12.4637% | |
| 1.5525% | |
| -12.0643% | |
| -16.9331% | |
| -12.2175% | |
| -0.7448% | |
| 21.9938% | |
| 35.5789% | |
| 35.9263% | |
| 23.1234% | |
| 7.4105% | |
| 1.8602% | |
| -4.7872% | |
| -3.4854% | |
| -1.0378% | |
| -0.4816% | |
| 3.2769% | |
| 11.2952% | |
| 20.1437% | |
| 19.5265% | |
| 20.5296% | |
| 13.1315% | |
| -0.9919% | |
| -4.0224% | |
| -6.2011% | |
| -0.632% | |
| 18.6145% | |
| 29.5304% | |
| 40.1432% | |
| 36.7119% | |
| 24.1549% | |
| 16.8856% | |
| 9.1859% | |
| 5.4125% | |
| 9.6174% | |
| 11.8206% | |
| 15.2997% | |
| 28.1929% | |
| 26.3842% | |
| 31.0591% | |
| 44.9916% | |
| 33.5531% | |
| 25.8518% | |
| 17.7831% | |
| -14.7776% | |
| -22.5721% | |
| -24.4101% | |
| -32.448% | |
| -18.832% | |
| -12.7711% | |
| -7.9061% | |
| 9.869% | |
| 10.6722% | |
| 15.7191% | |
| 18.2336% | |
| 11.9922% | |
| 16.7993% | |
| 16.9943% | |
| 20.3912% | |
| 29.527% | |
| 29.9492% | |
| 35.5925% | |
| 41.3068% | |
| 43.8443% | |
| 61.8274% | |
| 81.6534% | |
| 104.1362% | |
| 132.7856% | |
| 162.1211% | |
| 181.5466% | |
| 153.3314% | |
| 120.6004% | |
| 71.3546% | |
| 26.6526% | |
| 10.5802% | |
| -27.3803% | |
| -48.9991% |